XML 31 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Goodwill and Other Intangible Assets - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
product
Dec. 31, 2018
USD ($)
product
Dec. 31, 2017
USD ($)
product
Finite-Lived Intangible Assets [Line Items]      
Accumulated amortization $ 203,115 $ 217,600  
Amortization of intangibles 39,765 53,472 $ 61,443
Impairment of intangible assets 29,497 231,086 128,127
Goodwill impairment $ 15,955 0 0
Reporting unit, assumed control premium 20.90%    
Goodwill $ 267,923 $ 283,879 $ 285,310
IPR&D      
Finite-Lived Intangible Assets [Line Items]      
Number of IPR&D projects abandoned (in project) | product 1 18 3
Impairment of intangible assets $ 200    
Impairment of IPR&D projects $ 200 $ 139,461  
IPR&D | R&D expenses      
Finite-Lived Intangible Assets [Line Items]      
Impairment of IPR&D projects   139,500 $ 24,600
Minimum      
Finite-Lived Intangible Assets [Line Items]      
Useful life 1 year    
Maximum      
Finite-Lived Intangible Assets [Line Items]      
Useful life 30 years    
Product licensing rights      
Finite-Lived Intangible Assets [Line Items]      
Accumulated amortization $ 187,306    
Amortization of intangibles $ 38,236 $ 50,567  
Number of IPR&D projects abandoned (in project) | product 4 25 10
Impairment of intangible assets $ 29,297 $ 88,492  
Product licensing rights | R&D expenses      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible assets 29,500 91,600 $ 103,500
Prescription Pharmaceuticals      
Finite-Lived Intangible Assets [Line Items]      
Goodwill impairment $ 15,955 0  
Reporting unit, percentage of fair value in excess of carrying amount 7.90%    
Goodwill $ 251,206 $ 267,162 $ 268,593
Consumer Health      
Finite-Lived Intangible Assets [Line Items]      
Reporting unit, percentage of fair value in excess of carrying amount 25.50%    
Goodwill $ 16,700    
India      
Finite-Lived Intangible Assets [Line Items]      
Goodwill impairment $ 16,000